Cancer

Explore the complexities of Cancer research and treatment in China’s pharmaceutical industry. At Fineline Info & Tech, we provide reliable data, news, and insights to enhance your understanding and decision-making. Stay informed and stay ahead in the fight against cancer with flcube.com.

Yifan Pharmaceutical Secures China Rights to Boryung's Taxotere – Docetaxel Injection Commercialization Deal Covers Promotion, Distribution and Market Operations
CompanyDeals

Yifan Pharmaceutical Secures China Rights to Boryung’s Taxotere – Docetaxel Injection Commercialization Deal Covers Promotion, Distribution and Market Operations

Yifan Pharmaceutical Co., Ltd. (SHE: 002019) and Boryung Corporation (KRX: 003850) of South Korea announced a partnership agreement under which Yifan Pharmaceutical has obtained the general agency rights for Taxotere…

Novo Nordisk's Once‑Weekly CagriSema Proves Superior to Tirzepatide in Head‑to‑Head Weight Loss Trial – REDEFINE 9 Delivers 21.0% Reduction vs Placebo

Novo Nordisk’s Once‑Weekly CagriSema Proves Superior to Tirzepatide in Head‑to‑Head Weight Loss Trial – REDEFINE 9 Delivers 21.0% Reduction vs Placebo

Biokin's Bispecific ADC Izalontamab Bretecan Wins Eighth Breakthrough Therapy Designation in China – PD-1 Combo Targets First-Line PD-L1-Positive TNBC

Biokin’s Bispecific ADC Izalontamab Bretecan Wins Eighth Breakthrough Therapy Designation in China – PD-1 Combo Targets First-Line PD-L1-Positive TNBC

Empowering Chinese Pharma’s Global Expansion

Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.
Explore Now
CompanyDrug

Bristol Myers Squibb’s Krazati Meets Primary Endpoint in Late-Stage Lung Cancer Study

CompanyDrug

Pfizer’s Lorbrena Outperforms Xalkori in 5-Year ALK-Positive NSCLC Follow-Up

CompanyDrug

Innovent Biologics Presents Clinical Data for Pipeline Candidates at ASCO 2024

CompanyDrug

Gilead’s Trodelvy Misses Overall Survival Endpoint in Late-Stage Urothelial Cancer Study

CompanyDrug

Chipscreen’s Chidamide in Sight of Breakthrough Therapy Designation in China for MSS/pMMR Colorectal Cancer

CompanyDrug

CStone Pharmaceuticals’ Sugemalimab Receives Positive CHMP Opinion for NSCLC Treatment in Europe

CompanyDrug

FDA Extends Indication for BMS’ CAR-T Therapy Breyanzi to Include Relapsed MCL in Adults

CompanyDrug

Novartis Halts Development of KRAS Inhibitor Opnurasib Due to Competitive Market

Show More